ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET INTRODUCTION

Endoscopic Submucosal Dissection (ESD) is a procedure for removing precancerous and early-stage cancerous lesions from the gastrointestinal tract with minimally invasive endoscopic technique.

MARKET OVERVIEW

The endoscopic submucosal dissection market is valued at approximately USD 0.46 billion in 2024 and is projected to reach USD 1.12 billion by 2035 exhibiting a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2025-2035. With this advanced endoscopic technique, tumors are removed while preserving the healthy tissue around them, which offers several significant benefits for patients.

GROWTH DRIVERS

The ESD market is significantly influenced by the increasing incidence of gastrointestinal (GI) malignancies worldwide, which include colorectal, gastric, and esophageal cancers. Endoscopy has emerged as the main technique for identifying and removing precancerous and cancerous lesions in the GI tract as healthcare systems place a greater emphasis on early identification and minimally invasive treatment alternatives. Compared to open surgery, ESD provides a less intrusive surgical method for the en bloc removal of superficial tumors, while protecting organ function and minimizing patient trauma. For example, the American Cancer Society projected that 26,890 new instances of stomach cancer are expected in the US in 2024, thereby increasing demand for ESD.

The ESD market is experiencing substantial growth due to technological advancements. The advancement of 4K ultra-HD and high-definition (HD) imaging technologies has revolutionized ESD treatments by providing detailed visualization and greater optical clarity, both of which are essential for procedural success. The precision and safety of ESD are enhanced by improved electrosurgical knives like the FUJIFILM FushKnife and ClutchCutter. The use of AI and ML in endoscopic procedures is improving the diagnostic accuracy and procedural outcomes. For instance, Olympus' EVIS X1 system with Color Enhancement Imaging technology enhances lesion and polyp visibility. Furthermore, in October 2024, Odin Medical Ltd., an Olympus company, was granted U.S. FDA 510(k) approval for its CADDIE computer-aided detection (CADe) cloud-based artificial intelligence technology for colorectal polyp identification.

MARKET SEGMENTATION:

By Product -

·         Endoscopic Systems

o   Gastroscopes

o   Colonoscopes

·         ESD-specific Devices & Accessories

o   Knives

o   Injection Agents

o   Tissue Retractors

o   Graspers/Clips

o   Other Accessories 

By Indication –

·         Stomach/ Gastric Cancer

·         Colon/ Colorectal Cancer

·         Esophaegeal Cancer

By End User –

·         Hospital

·         Specialty Clinics

·         Ambulatory Surgical Centers

·         Others

By Region -

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Endoscopic Submucosal Dissection Market By Product Segment Review:

Endoscopic devices, which offer superior vision capabilities, are crucial for both diagnosis and therapy. The demand for endoscopic systems is driven by the technological developments, expanding clinical acceptance and training in Western healthcare systems, and the increasing demand for effective, minimally invasive treatments for a growing number of gastrointestinal cancer cases worldwide.

Endoscopic Submucosal Dissection Market By Indication Segment Review:

In 2025, Stomach/ Gastric Cancer segment is anticipated to hold the largest share of the market due to the rising incidence of stomach cancer worldwide, technological developments in endoscopic instruments (such as high-definition endoscopes and better electrosurgical knives), and the incorporation of artificial intelligence (AI) for improved diagnostic precision.

Endoscopic Submucosal Dissection Market By End User Segment Review:

In 2025, hospital’ segment is anticipated to hold the largest share of the market, primarily driven by their access to cutting-edge equipment, highly qualified staff, and the ability to handle complications following surgery.

Endoscopic Submucosal Dissection Market By Region Segment Review:

The endoscopic submucosal dissection market exhibits significant regional variations, with APAC leading the market in 2024 due to the rising healthcare expenditures, less stringent regulatory frameworks, economic development attracting foreign investments, and a growing geriatric population with chronic diseases.

Endoscopic Submucosal Dissection Market Regional Synopsis:

The market in North America is witnessing growth due to their advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological innovation.

The European market is expected to experience moderate growth, fueled by the rapid technological advancements, the expanding healthcare sector, and the rising preference for minimally invasive surgeries.

The Asia Pacific market is poised for continuous growth due to their burgeoning healthcare infrastructure, increasing awareness of early cancer detection, favorable regulatory support, and the region's expertise in the development and adoption of ESD techniques.

The Latin American market is experiencing growth due to the advancements in medical technology, increasing prevalence of gastrointestinal cancers, and a growing recognition of ESD's benefits over traditional surgical methods.

The expansion of the endoscopic submucosal dissection market in the Middle East and Africa is driven by the increasing prevalence of gastrointestinal cancers, a growing geriatric population, and advancements in healthcare infrastructure.

Endoscopic Submucosal Dissection Market Key Challenges:

The high overhead cost of ESD procedures and limited reimbursement frameworks in some regions is one of the primary factors hindering the market growth of endoscopic submucosal dissection. Although there is a growing awareness of ESD and improved training access in Western countries, the cost-effectiveness and reimbursement policies still poses a challenge. The overall exp is impacted by the specialized instruments needed for ESD, which include various types of knives, injection agents, and hemostatic devices. The initial equipment investment and continuing expenses related to hiring and retaining qualified staff often become significant for healthcare organizations.

Endoscopic Submucosal Dissection Market Competitive Landscape:

The global endoscopic submucosal dissection market is highly competitive, characterized by mix of established medical device manufacturers, specialized endoscopy equipment providers, and emerging players, each striving to enhance their market presence through various strategies such as product launches and technological advancements, mergers, acquisitions, and collaborations, geographical expansion, training and education, focus on minimally invasive procedures and early cancer detection, integration of ai and automation, and adherence to strict regulatory requirements and favorable reimbursement policies.

Companies are increasingly prioritizing product innovations in this market. Businesses are making significant investment in research and development to launch new and advanced products that enhance procedural efficiency and clinical outcomes.

Endoscopic Submucosal Dissection Market Key Players:

·         Erbe Elektromedizin GmbH

·         Sumitomo Bakelite Co., Ltd.

·         Ovesco Endoscopy AG

·         FUJIFILM Holdings Corporation

·         Olympus Corporation

·         Boston Scientific Corporation

·         ZEON CORPORATION

·         Medtronic

·         Micro-Tech Endoscopy

·         Other Key & Niche Players